These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25311739)

  • 21. Epigenetic alterations in acute myeloid leukemias.
    Mehdipour P; Santoro F; Minucci S
    FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia.
    Nadeu F; Diaz-Navarro A; Delgado J; Puente XS; Campo E
    Annu Rev Pathol; 2020 Jan; 15():149-177. PubMed ID: 31977296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic deregulation in myeloid malignancies.
    Meldi KM; Figueroa ME
    Transl Res; 2015 Jan; 165(1):102-14. PubMed ID: 24813528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.
    Malcovati L; Ambaglio I; Elena C
    Curr Opin Oncol; 2015 Nov; 27(6):551-9. PubMed ID: 26352542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Majeti R
    Best Pract Res Clin Haematol; 2014; 27(3-4):229-34. PubMed ID: 25455271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation technologies and data analytical approaches for epigenomics.
    Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T
    Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic changes: a common theme in acute myelogenous leukemogenesis.
    Gutierrez SE; Romero-Oliva FA
    J Hematol Oncol; 2013 Aug; 6():57. PubMed ID: 23938080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetics in AML.
    Melnick AM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients.
    von der Heide EK; Neumann M; Vosberg S; James AR; Schroeder MP; Ortiz-Tanchez J; Isaakidis K; Schlee C; Luther M; Jöhrens K; Anagnostopoulos I; Mochmann LH; Nowak D; Hofmann WK; Greif PA; Baldus CD
    Leukemia; 2017 May; 31(5):1069-1078. PubMed ID: 27833093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting AML at the intersection of epigenetics and signaling.
    Narayan N; Huntly BJP
    Sci Signal; 2022 Apr; 15(730):eabo0059. PubMed ID: 35439022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.
    Claus R; Plass C; Armstrong SA; Bullinger L
    Future Oncol; 2010 Sep; 6(9):1415-31. PubMed ID: 20919827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation as a pathogenic event and as a therapeutic target in AML.
    Schoofs T; Müller-Tidow C
    Cancer Treat Rev; 2011; 37 Suppl 1():S13-8. PubMed ID: 21612874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles.
    Yang XH; Wang B; Cunningham JM
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S6. PubMed ID: 26043758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.
    Martín V; Valencia A; Agirre X; Cervera J; San Jose-Eneriz E; Vilas-Zornoza A; Rodriguez-Otero P; Sanz MA; Herrera C; Torres A; Prosper F; Román-Gómez J
    Cancer Sci; 2010 Feb; 101(2):425-32. PubMed ID: 19874313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next generation sequencing of acute myeloid leukemia: influencing prognosis.
    Ilyas AM; Ahmad S; Faheem M; Naseer MI; Kumosani TA; Al-Qahtani MH; Gari M; Ahmed F
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S5. PubMed ID: 25924101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer epigenomics: beyond genomics.
    Sandoval J; Esteller M
    Curr Opin Genet Dev; 2012 Feb; 22(1):50-5. PubMed ID: 22402447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.